Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care...
Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations...
View ArticleTurkey’s Biopharmaceutical Sector Attracts, Boosts Research and Development...
A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth....
View ArticleDrug Discovery On Demand By Molplex
An innovative new online “drug discovery on demand” platform has been launched by Molplex, a company specializing in products and services for the life sciences. Designed to help drug discovery groups...
View ArticleNationaly Registered T-Protocol Of Genom Project Successfully Applied To...
Division of Gene Medicine & Stem Cell Application, School of Medical Science, complete the research and established completely new protocol totally recovering natural bio mechanism of hair...
View ArticleGene Therapy and Stem Cell Therapy Standard Developed For A Unique Derivative...
Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned...
View ArticleAssay-Ready Chemistry Partnership between Enamine and Molplex
Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply...
View ArticleMicroTissues, Inc.’s 3D Petri Dish™ Used in Time Magazine’s Medical...
MicroTissues, Inc. announced today that its 3D Petri Dish™ was used in one of Time magazine’s medical breakthroughs of 2010. Researchers at Brown University and Women and Infants Hospital used the 3D...
View ArticleMicroTissues, Inc.’s 3D Petri Dish™ Is Helping to Reduce Animal Use in Research
MicroTissues, Inc. announced today that its 3D Petri Dish™ is targeted towards helping to reduce the numbers of animals used in research. The 3D Petri Dish™ is a new tool for the world wide industry of...
View ArticleMicroTissues, Inc. Announces New Product Launch for the 3D Petri Dish™
MicroTissues, Inc. announced today the launch of its 3D Petri Dish™ line of products. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery. Invented...
View ArticleInvestor Stem Cell Launches Online Discussion Community Dedicated To Stem...
Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements...
View ArticleAdvanced Liquid Logic Licenses Patents, Creates Collaboration With CEA-Leti
Advanced Liquid Logic announced today that it has signed a license and collaboration agreement with the French research institute CEA-Leti. The agreement provides Advanced Liquid Logic with worldwide...
View ArticleGenQual Announces Initial Closing Of Its First Preferred Equity Funding Round
GenQual is pleased to announce initial closing of its first preferred equity round. Financial terms were not disclosed. This inaugural funding round allows GenQual to pursue proof-of-principle testing...
View ArticleCYTOO Raises 10 M$ (7M€) in Series C Round
CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the...
View ArticleAdvinus, SignalChem Start The Multi-Year, Multi-Target Collaboration On New...
Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started...
View ArticleSprint Bioscience Strengthens Its Cancer Metabolism Portfolio
Sprint Bioscience, a Swedish company developing oncology therapeutics targeting cancer metabolism, announced today that it has raised money to strengthen its drug discovery portfolio. The investment by...
View ArticleMicrotissues® Inc. and Sigma-Aldrich® Sign Worldwide Supply and Distribution...
Microtissues® Inc. announced today the signing of a Supply and Distribution Agreement with Sigma-Aldrich® Corporation (Nasdaq: SIAL) for the worldwide sales and marketing of the 3D Petri Dish®, a new...
View ArticleInnovative Drug Discovery Business, Biosortia Pharmaceuticals, Lands Two...
Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November...
View ArticleLC Sciences Launches Online Searchable Knowledgebase
LC Sciences, LLC, a leading provider of microRNA analysis services, today announced the launch of a new online searchable knowledgebase that researchers can use to locate technical information on the...
View ArticleHD Biosciences and Anchor Therapeutics Form Collaboration for Co-marketing...
HD Biosciences Co., Ltd (HDB) and Anchor Therapeutics, Inc. today announced that they have formed a strategic collaboration to co-develop and co-market Anchor’s proprietary pepducin technology and...
View ArticleHD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research...
HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the...
View Article
